Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma.
Andreadis C, Schuster SJ, Chong EA, Svoboda J, Luger SM, Porter DL, Tsai DE, Nasta SD, Elstrom RL, Goldstein SC, Downs LH, Mangan PA, Cunningham KA, Hummel KA, Gimotty PA, Siegel DL, Glatstein E, Stadtmauer EA. Andreadis C, et al. Among authors: schuster sj. Bone Marrow Transplant. 2005 Dec;36(11):955-61. doi: 10.1038/sj.bmt.1705178. Bone Marrow Transplant. 2005. PMID: 16205727
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy.
Moore HC, Mick R, Solin LJ, Sickles C, Mangan PA, Luger SM, Fox KR, Schuchter LM, Loh E, Porter DL, Schuster S, Buzby GP, Glatstein E, Silberstein LE, Stadtmauer EA. Moore HC, et al. Ann Oncol. 1999 Aug;10(8):929-36. doi: 10.1023/a:1008393204854. Ann Oncol. 1999. PMID: 10509154 Free article. Clinical Trial.
Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination.
Stadtmauer EA, Tsai DE, Sickles CJ, Mick R, Luger SM, Porter DL, Mangan PA, Schuchter LM, Schuster SJ, Loh EY, Magee DA, Sachs RA, Wall ME, Moore J, Buzby GP, Zaleta E, Kamoun M, Silberstein LE. Stadtmauer EA, et al. Among authors: schuster sj. Med Oncol. 1999 Dec;16(4):279-88. doi: 10.1007/BF02785874. Med Oncol. 1999. PMID: 10618691 Clinical Trial.
Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation.
Porter DL, Luger SM, Duffy KM, Stadtmauer EA, Laport G, Schuster SJ, Orloff G, Tsai D, McDaid K, Kathakali A, Leonard DG, Antin JH. Porter DL, et al. Among authors: schuster sj. Biol Blood Marrow Transplant. 2001;7(4):230-8. doi: 10.1053/bbmt.2001.v7.pm11349810. Biol Blood Marrow Transplant. 2001. PMID: 11349810 Free article. Clinical Trial.
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients.
Tsai DE, Hardy CL, Tomaszewski JE, Kotloff RM, Oltoff KM, Somer BG, Schuster SJ, Porter DL, Montone KT, Stadtmauer EA. Tsai DE, et al. Among authors: schuster sj. Transplantation. 2001 Apr 27;71(8):1076-88. doi: 10.1097/00007890-200104270-00012. Transplantation. 2001. PMID: 11374406
Acute myelogenous leukemia: advances and limitations of treatment.
Parisi E, Draznin J, Stoopler E, Schuster SJ, Porter D, Sollecito TP. Parisi E, et al. Among authors: schuster sj. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Mar;93(3):257-63. doi: 10.1067/moe.2002.121988. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002. PMID: 11925533 Review.
256 results